-
公开(公告)号:US20070027185A1
公开(公告)日:2007-02-01
申请号:US10571373
申请日:2004-09-24
Applicant: Jeffry Franciskovich , Theodore Goodson , David Herron , Angela Marquart , John Masters , David Mendel , Leander Merritt , Andrew Ratz , Gerald Smith , Michael Wiley , Ying Yee
Inventor: Jeffry Franciskovich , Theodore Goodson , David Herron , Angela Marquart , John Masters , David Mendel , Leander Merritt , Andrew Ratz , Gerald Smith , Michael Wiley , Ying Yee
IPC: A61K31/4545 , A61K31/444 , C07D401/02
CPC classification number: C07C49/84 , C04B35/632 , C07C65/05 , C07C65/21 , C07D213/81 , C07D295/155 , C07D317/30 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/14
Abstract: This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.
Abstract translation: 本申请涉及如本文所定义的式I化合物(或其前体药物或其药学上可接受的盐),其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途,以及 作为其制备方法及其中间体。
-
公开(公告)号:US20050090483A1
公开(公告)日:2005-04-28
申请号:US10506459
申请日:2003-03-04
Applicant: Thomas Engler , Timothy Burkholder , Joshua Clayton , Clive Diefenbacher , Kelly Furness , James Henry , Yihong Li , Sushant Malhotra , Angela Marquart , Johnathan McLean , David Mendel , Jon Reel
Inventor: Thomas Engler , Timothy Burkholder , Joshua Clayton , Clive Diefenbacher , Kelly Furness , James Henry , Yihong Li , Sushant Malhotra , Angela Marquart , Johnathan McLean , David Mendel , Jon Reel
IPC: A61K31/407 , A61K31/4355 , A61K31/4745 , A61K31/55 , A61K31/5513 , A61P3/10 , A61P25/08 , A61P25/28 , A61P43/00 , C07D471/06 , C07D487/06 , C07D498/06 , C07D519/00 , A61K31/551 , C07D487/14
CPC classification number: C07D471/06 , C07D487/06
Abstract: The present invention provides kinase inhibitors of Formula I.
Abstract translation: 本发明提供式I的激酶抑制剂。
-